.webp/jcr:content.webp)
Cardiovascular Diseases
Learn about the latest trends, discover events and innovations in the changing world of cardiovascular disease.
Science in Cardiovascular Diseases
Get a 360º view and stay up-to-date on cardiovascular disease with content selected for you

- Dyslipidemia
- Dyslipidemia
Prospective evaluation of lipid management following ACS in Saudi Arabia (ACOSYM Study)

- Dyslipidemia
Acute LDL-C Reduction Post ACS: Strike Early and Strike Strong: From Evidence to Clinical Practice

- Dyslipidemia
- Cardiovascular
Should we encourage earlier and broader use of combination therapies in dyslipidemia?
.jpg/jcr:content/aha-thumb%20(1).jpg)
- Dyslipidemia
- Cardiovascular
ACC/AHA vs ESC/EAS LDL–C recommendations for residual risk reduction in ASCVD: A simulation study from Da Vinci
Inspiration and innovation
Get inspired and stay at the forefront of innovation with the following resources
.webp/jcr:content/Lipid-lowering-therapy-thumb%20(2).webp)
- Dyslipidemia
- Cardiovascular
Lipid-lowering therapy and care gap in patients with Familial Hypercholesterolemia
-from-the-SAFEHEART-registry.webp/jcr:content/Clinical%20practice%20experience%20in%20patients%20with%20familial%20hypercholesterolemia%20(FH)%20from%20the%20SAFEHEART%20registry.webp)
- Cardiovascular
- Dyslipidemia
Clinical practice experience in patients with familial hypercholesterolemia (FH) from the Safeheart registry
Proprotein convertase subtilisin/kexin type 9 inhibitors for heterozygous familial hypercholesterolemia: A clinical practice experience from the Safeheart registry

- Atherothrombosis
- Cardiovascular
- Atherothrombosis
No Rebound Effect Post Clopidogrel Withdrawal

- Dyslipidemia
- Cardiovascular
- Dyslipidemia
Statin/ezetimibe SPC for better adherence to LLT
.jpg/jcr:content/cardio-newest-thumb%20(1).jpg)
- Dyslipidemia
- Cardiovascular
Single-Pill Combinations in Dyslipidemia
This review describes the potential benefits of combination treatment and presents data supporting the use of single-pill combination (SPC) for increasing exposure to lipid-lowering treatment (LLT).
Events
Stay up to date and register for the latest events and view webinar recordings.
